Patient info Open main menu

Enerzair Breezhaler 114 micrograms / 46 micrograms / 136 micrograms inhalation powder hard capsules – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
114 micrograms / 46 micrograms / 136 micrograms
Contains active substances:

Patient leaflet - Enerzair Breezhaler 114 micrograms / 46 micrograms / 136 micrograms inhalation powder hard capsules

1. What Enerzair Breezhaler is and what it is used for What Enerzair Breezhaler is and how it works

Enerzair Breezhaler contains three active substances:

  • indacaterol
  • glycopyrronium
  • mometasone furoate

Indacaterol and glycopyrronium belong to a group of medicines called bronchodilators. They work in different ways to relax the muscles of the small airways in the lungs. This helps to open the airways and makes it easier for air to get in and out of the lungs. When they are taken regularly, they help the small airways to remain open.

Mometasone furoate belongs to a group of medicines called corticosteroids (or steroids). Corticosteroids reduce the swelling and irritation (inflammation) in the small airways in the lungs and so gradually ease breathing problems. Corticosteroids also help to prevent attacks of asthma.

What Enerzair Breezhaler is used for

Enerzair Breezhaler is used regularly as treatment for asthma in adults. Asthma is a serious, long-term lung disease where the muscles around the smaller airways become tight (bronchoconstriction) and inflamed. Symptoms come and go and include shortness of breath, wheezing, chest tightness and cough. You should use Enerzair Breezhaler every day and not only when you have breathing problems or other symptoms of asthma. This will ensure that it controls your asthma properly. Do not use this medicine to relieve a sudden attack of breathlessness or wheezing.

If you have any questions about how Enerzair Breezhaler works or why this medicine has been prescribed for you, ask your doctor.

2. What you need to know before you use Enerzair Breezhaler

Follow all the doctor’s instructions carefully.

Do not use Enerzair Breezhaler

  • if you are allergic to indacaterol, glycopyrronium, mometasone furoate, or any

    of the other ingredients of this medicine (listed in section 6). If you think you may be allergic, ask your doctor for advice.

Warnings and precautions

Talk to your doctor, pharmacist or nurse before using Enerzair Breezhaler if any of the following applies to you:

  • if you have heart problems, including an irregular or fast heartbeat. - if you have thyroid gland problems.
  • if you have ever been told you have diabetes or high blood sugar. - if you suffer from seizures or fits.
  • if you have severe kidney problems.
  • if you have severe liver problems.
  • if you have a low level of potassium in your blood.
  • if you have an eye problem called angle-closure glaucoma. - if you have difficulty passing urine.
  • if you have tuberculosis (TB) of the lung, or any long standing or

    untreated infections.

During treatment with Enerzair Breezhaler

Stop using this medicine and get medical help immediately if you have any of the following:

  • tightness of the chest, coughing, wheezing or breathlessness immediately after

    using Enerzair Breezhaler (signs the medicine is unexpectedly tightening the

    airways, known as paradoxical bronchospasm).

  • difficulty breathing or swallowing, swelling of the tongue, lips or face, skin rash,

    itching and hives (signs of allergic reaction).

  • eye pain or discomfort, temporary blurring of vision, visual haloes (seeing bright

    circles around lights) or coloured images in association with red eyes (signs of an attack of angle-closure glaucoma).

Children and adolescents

Do not give this medicine to children or adolescents (below the age of 18 years) because it has not been studied in this age group.

Other medicines and Enerzair Breezhaler

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines. In particular, tell your doctor or pharmacist if you are using: - medicines that decrease the level of potassium in your blood. These include

diuretics (which increase urine production and can be used to treat high blood pressure, e.g. hydrochlorothiazide), other bronchodilators such as methylxanthines used for breathing problems (e.g. theophylline) or corticosteroids (e.g. prednisolone).

  • tricyclic antidepressants or monoamine oxidase inhibitors (medicines used in

    the treatment of depression).

  • any medicines that may be similar to Enerzair Breezhaler (contain similar active

    substances); using them together may increase the risk of possible side effects. - medicines called beta blockers used to treat high blood pressure or other heart

    problems (e.g. propranolol) or to treat glaucoma (e.g. timolol). - ketoconazole or itraconazole (medicines used to treat fungal infections). - ritonavir, nelfinavir or cobicistat (medicines used to treat HIV infection).

Pregnancy and breast‑feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Your doctor will discuss with you whether you can use Enerzair Breezhaler.

Driving and using machines

It is unlikely that this medicine will affect your ability to drive and use machines.

Enerzair Breezhaler contains lactose

This medicine contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

3. How to use Enerzair Breezhaler

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

How much Enerzair Breezhaler to inhale

The usual dose is to inhale the content of one capsule each day. You only need to use the medicine once a day. Do not use more than your doctor tells you to use.

You should use Enerzair Breezhaler every day, even when your asthma is not troubling you.

When to inhale Enerzair Breezhaler

Inhale Enerzair Breezhaler at the same time each day. This will help control your symptoms throughout the day and night. It will also help you to remember to use it.

How to inhale Enerzair Breezhaler

  • Enerzair Breezhaler is for inhalation use.
  • In this pack, you will find an inhaler and capsules that contain the medicine. The

    inhaler enables you to inhale the medicine in the capsule. Only use the capsules with the inhaler provided in this pack. The capsules should remain in the blister until you need to use them.

  • Peel the backing away from the blister to open it, do not push the capsule

    through the foil.

  • When you start a new pack, use the new inhaler supplied in this new pack. - Dispose of the inhaler in each pack after all capsules in that pack have

    been used.

  • Do not swallow the capsules.

‑ Please read the instructions for use on the other side of this leaflet for more information on how to use the inhaler.

IIf your symptoms do not improve

If your asthma is not getting better or if it gets worse after you have started using Enerzair Breezhaler, talk to your doctor.

If you use more Enerzair Breezhaler than you should

If you accidently inhale too much of this medicine, contact your doctor or hospital for advice immediately. You may need medical attention.

If you forget to use Enerzair Breezhaler

If you forget to inhale a dose at the usual time, inhale one as soon as possible on that day. Then inhale the next dose at the usual time on the next day. Do not inhale two doses on the same day.

If you stop using Enerzair Breezhaler

Do not stop using Enerzair Breezhaler unless your doctor tells you to. Your asthma symptoms may come back if you stop using it.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some side effects could be serious

Stop using Enerzair Breezhaler and get medical help immediately if you have any of the following:

Common: may affect up to 1 in every 10 people

  • difficulty breathing or swallowing, swelling of the tongue, lips or face, skin rash, itching and hives (signs of allergic reaction).

Other side effects

Other side effects include the following listed below. If these side effects become severe, please tell your doctor, pharmacist or nurse.

Very common: may affect more than 1 in 10 people

  • sore throat
  • runny nose (nasopharyngitis)
  • sudden difficulty breathing and feeling of tightness in chest with wheezing or coughing (asthma exacerbation)

Common: may affect up to 1 in every 10 people

  • oral thrush (sign of candidiasis). After you have finished taking your dose, rinse your mouth with water or a mouthwash solution and then spit this out. This will help to prevent thrush.
  • a frequent urge to urinate and pain or burning when urinating (signs of urinary tract infection)
  • headache
  • fast heart beat
  • cough
  • voice alteration (hoarseness)
  • diarrhoea, abdominal cramps, nausea, and vomiting (gastroenteritis) - pain in muscles, bones or joints (signs of musculoskeletal pain) - muscle spasm
  • fever
  • upper respiratory tract infection
  • oropharyngeal pain

Uncommon: may affect up to 1 in every 100 people

  • dry mouth
  • rash
  • high level of sugar in the blood (hyperglycaemia)
  • skin itching
  • difficulty and pain when passing urine (signs of dysuria)
  • clouding of the lens of your eyes (signs of cataract)

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Enerzair Breezhaler

  • Keep this medicine out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the carton and blister after “EXP”. The expiry date refers to the last day of that month. - Do not store above 30°C.
  • Store the capsules in the original blister, in order to protect from light and moisture, and do not remove until immediately before use.
  • Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Enerzair Breezhaler contains

  • The active substances are indacaterol (as acetate), glycopyrronium (as bromide) and mometasone furoate. Each capsule contains 150 micrograms indacaterol (as acetate), 63 micrograms glycopyrronium bromide (equivalent to 50 micrograms glycopyrronium) and 160 micrograms mometasone furoate. Each delivered dose (the dose that leaves the mouthpiece of the inhaler) contains 114 micrograms indacaterol (as acetate), 58 micrograms glycopyrronium bromide (equivalent to 46 micrograms glycopyrronium) and 136 micrograms mometasone furoate.
  • The other ingredients of the capsule are lactose monohydrate and magnesium stearate (see “Enerzair Breezhaler contains lactose” in section 2). - The ingredients of the capsule shell are hypromellose, carrageenan, potassium chloride, iron oxide, yellow (E172), indigo carmine (E132), water, purified and printing ink.

    ° The ingredients of the printing ink are iron oxide, black (E172), isopropyl alcohol, propylene glycol (E1520), hypromellose (E464) and water, purified.

What Enerzair Breezhaler looks like and contents of the pack

In this pack, you will find an inhaler together with capsules in blisters. The capsules are transparent and contain a white powder. They have a black product code “IGM150-50-160” printed above two black bars on the body with a logo printed in black and surrounded by a black bar on the cap.

The following pack sizes are available:

Single pack containing 10 x 1, 30 x 1 or 90 x 1 hard capsules, together with 1 inhaler.

Multipacks comprising 15 cartons, each containing 10 x 1 hard capsules together with 1 inhaler.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Novartis Pharmaceuticals UK Limited

2nd Floor, The WestWorks Building, White City Place 195 Wood Lane

London

W12 7FQ

United Kingdom

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

United Kingdom

Novartis Pharmaceuticals UK Ltd.

Tel: +44 1276 698370

This leaflet was last revised in June 2026

3601270-B25-GB

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 00101/1209

Last revision stated in the text: June 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Enerzair Breezhaler 114 micrograms / 46 micrograms / 136 micrograms inhalation powder hard capsules

Prescription needed? Yes, prescription-only medicine (POM)
Active substances Glycopyrronium bromide, Mometasone, Indacaterol
Strength 114 micrograms / 46 micrograms / 136 micrograms
Pharmaceutical form Inhalation powder
Capsule with green transparent cap and uncoloured transparent body containing a white powder, with the product code “IGM150-50-160” printed in black above two black bars on the body and with the product logo printed in black and surrounded by a black bar on the cap.
How is it taken Inhalation
Excipients Lactose monohydrate, Magnesium stearate, Hypromellose, Carrageenan, Potassium chloride, Iron oxide, yellow (E172), Indigo carmine (E132), Water, purified, Iron oxide, black (E172), Isopropyl alcohol, Propylene glycol (E1520), Hypromellose (E464)
Pack sizes 30 capsule
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years.
Storage Do not store above 30°C.
Store in the original package in order to protect from light and moisture.
Drug group (ATC) Drugs for obstructive airway diseases, adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
  1. R Respiratory system drugs
    1. R03 Drugs for obstructive airway diseases
      1. R03A Adrenergics, inhalants
        1. R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
          1. R03AL12 indacaterol, glycopyrronium bromide and mometasone
Marketing authorisation PLGB 00101/1209 (first authorised 5 June 2025)
Marketing authorisation holder Novartis Pharmaceuticals UK Limited
Codes GTIN 7613421042295 · BNF 03020000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.